INDUSTRY
Deloitte 2019 Global Life Sciences Outlook Deloitte is one of the premier consulting companies in the world. It has more than 286,200 professionals globally, and is the 4th largest privately owned company in the United States. Deloitte has been ranked number one by market share in consulting by Gartner, and for the fourth consecutive year, Kennedy Consulting Research and Advisory ranks Deloitte number one in both global consulting and management consulting based on aggregate revenue. So it makes sense to be alert to their wisdom about our industry. Here’s a brief summary of their recent Global Life Sciences Outlook for the year. To access the whole report, go here.
Partnerships, patients and data Strategic transformation is at the core of life science companies as they build new business models for the future. To accelerate change, focus will be on developing innovative and relationship-driven partnerships and creating real value for patients. Data is now the currency of life sciences, and mobilizing data throughout the enterprise, transforming work, and using technology symbiotically will be fundamental to advancing digital transformation. In 2019, the life sciences sector will see a strategic rise of the digital mindset and further adoption of transformative technologies. While traditional investment vehicles, like mergers & acquisitions, can expect a sharper focus, external innovation can become a meaningful culture change-agent through innovative and creative partnerships with new entrants and nontraditional players.
33 | HS&M MAY/JUNE 2019
Chart 1
